Closed Loop Medicine

Key Facts

Closed Loop Medicine is a healthcare company developing drug+SaMD combination products, transforming drug effectiveness by providing every drug with its real time digital companion. To date the company has raised a total of over £22 million (c. £$30 million) since founding. The company was founded by an experienced team of healthcare professionals, entrepreneurs and life scientists with experience of both drug and software development, as well as extensive health system innovation experience. Closed Loop Medicine is developing a new product class, a combinational therapy that binds drug therapy with digital therapy to personalise care for patients. Whilst the company is currently focused on products for hypertension and sleep, it aims to further develop its pipeline with additional single-prescription combination products for a wide portfolio of chronic diseases, ensuring that both patient and clinician are at the centre of its products and solutions.

Successes in UK/NHS

Key clinical partnership with Queen Mary University London and Bart’s Health for an interventional clinical trial as well as existing engagements with UCLP and Eastern AHSN. Professor David Collier is the lead investigator for the clinical trial. Contact details available on request.

Company details

Solutions

Delivering advanced patient care

Specialism

Digitally-enabled out of hospital care

Company details

Want to connect with this innovator?

Make an enquiry

Markets already exporting to

None

Desired Markets

USA, EU, India, Asia Pac

Desired customer types

Pharma, Generics and Healthcare Providers

Want to connect with this innovator?
Make an enquiry
Close
This field is required
This field is required
This field is required
This field is required
This field is required

Thank you

We are processing your request and will return your contact as soon as possible.